Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Nuclear Medicine

Free Subscription 09.03.2026 1 Ann Neurol 5 Ann Nucl Med 11 Clin Nucl Med 3 J Nucl Cardiol 3 J Nucl Med 4 Nucl Med Commun 1 Proc Natl Acad Sci U S A 1 Semin Nucl Med

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. FABBRI M, Del Campo N, Meissner WG, Rousseau V, et al
   Disease Progression in Multiple System Atrophy: The ASPIRE Multi-Modal Biomarker Study.
   Ann Neurol. 2026;99:96-113.
   PubMed         Abstract available
   
   

   
   Ann Nucl Med

2. KITANO Y, Miyake KK, Nobashi TW, Ishimori T, et al
   Response to the comment on "Subcutaneous/cutaneous uptake in the cancer-affected breast on (18)F-FDG PET/CT: association with post-surgical prognosis in breast cancer patients".
   Ann Nucl Med. 2026 Mar 6. doi: 10.1007/s12149-026-02186.
   PubMed        
   
   
3. CHEN L, Huang Z
   Comment on "Subcutaneous/cutaneous uptake in the cancer-affected breast on 18F-FDG PET/CT: association with post-surgical prognosis in breast cancer".
   Ann Nucl Med. 2026 Mar 3. doi: 10.1007/s12149-026-02185.
   PubMed        
   
   
4. DENIZMEN ZORBA D, Has Simsek D, Arslan DF, Isik EG, et al
   Diagnostic value of (6)(8)Ga-DOTATATE PET/CT volumetric parameters in differentiating adrenal lesions.
   Ann Nucl Med. 2026 Mar 3. doi: 10.1007/s12149-026-02175.
   PubMed        
   
   
5. CIFTCI E, Akovali B, Gumusgoz HS, Erkek BK, et al
   Predictive value of the (68)Ga-PSMA-11 PET/CT PRIMARY score for pathological upgrading in patients with ISUP Grade 1 prostate cancer and PSA < 20 ng/mL undergoing radical prostatectomy.
   Ann Nucl Med. 2026 Mar 3. doi: 10.1007/s12149-026-02179.
   PubMed         Abstract available
   
   
6. WACHI K, Yamao T, Miwa K, Miyaji N, et al
   Semi-quantitative tau PET approaches for Braak staging: concordance of CenTauRz and STOC with visual assessment.
   Ann Nucl Med. 2026 Mar 2. doi: 10.1007/s12149-026-02184.
   PubMed         Abstract available
   
   

   
   Clin Nucl Med

7. RAEISI N, Saber Tanha A, Aghaee A, Askari E, et al
   Detection of Peritoneal Carcinomatosis in Prostate Cancer via 99m Tc-HYNIC-PSMA-11 Scintigraphy.
   Clin Nucl Med. 2026;51:e239-e240.
   PubMed         Abstract available
   
   
8. LV Y, Li M, Lan X, Qin C, et al
   FAPI-Negative but FDG-Avid Hepatocellular Carcinoma With Extensive Steatosis.
   Clin Nucl Med. 2026;51:e274-e275.
   PubMed         Abstract available
   
   
9. SHU Q, Feng Y, Sun G, Cao N, et al
   Intense 18 F-FDG Activity of Aneurysmal Bone Cyst.
   Clin Nucl Med. 2026;51:371-372.
   PubMed         Abstract available
   
   
10. ROSELAND ME, Fitzpatrick KJ, Lu Z, Suresh K, et al
    Assessing PSMA Receptor Availability Using 68Ga-PSMA-11 PET/CT Following 177Lu-PSMA-617 Therapy Administration.
    Clin Nucl Med. 2026;51:316-319.
    PubMed         Abstract available
    
    
11. WANG J, Kuker R
    Brain and Spinal Leptomeningeal Metastases in Prostate Cancer Detected by PSMA PET and MRI Fusion.
    Clin Nucl Med. 2026;51:332-334.
    PubMed         Abstract available
    
    
12. BEKKHOUCHA A, Agrigoroaie L, Deandreis D, Guyon D, et al
    Lung Metastases from Meningioma Diagnosed on Whole Body 68Ga-DOTATOC PET/CT and Successfully Targeted With 177Lu-DOTATATE.
    Clin Nucl Med. 2026;51:335-337.
    PubMed         Abstract available
    
    
13. LIU Y, Cui Y, Zhou X, Liu Y, et al
    Negative 68Ga-FAPI-04 Uptake on PET/CT in HNF-1alpha-mutated Hepatocellular Adenoma: A Distinctive Feature for Differentiating From Hepatocellular Carcinoma.
    Clin Nucl Med. 2026;51:338-340.
    PubMed         Abstract available
    
    
14. GENG J, Luo J, Huang F, Qian J, et al
    FDG PET/CT in Duodenal Follicular Dendritic Cell Sarcoma.
    Clin Nucl Med. 2026;51:346-348.
    PubMed         Abstract available
    
    
15. SONI K, Cicero S, Syed R, Horan N, et al
    Sjogren Syndrome Associated Limbic Encephalitis and Its Longitudinal Brain FDG PET Manifestations.
    Clin Nucl Med. 2026;51:360-361.
    PubMed         Abstract available
    
    
16. CUI J, Ou R, Cao Z, Yan J, et al
    Primary Clear Cell Adenocarcinoma of the Female Urethra: A Case Report of a Rare Disease.
    Clin Nucl Med. 2026;51:e236-e238.
    PubMed         Abstract available
    
    
17. KIM YS, Park DG, Ahn YS, Yoon JH, et al
    Role of Dual-Phase 18F FP-CIT PET for Subtyping of Multiple System Atrophy.
    Clin Nucl Med. 2026;51:e219-e226.
    PubMed         Abstract available
    
    

    
    J Nucl Cardiol

18. DI CARLI MF
    SPECT's next act in nuclear cardiology.
    J Nucl Cardiol. 2026;56:102655.
    PubMed        
    
    
19. TERSALVI G, Carey P, Garmany A, Scott CG, et al
    Comparative performance of (99m)Tc-pyrophosphate vs. (99m)Tc-hydroxymethylene diphosphonate for cardiac amyloid radionuclide imaging.
    J Nucl Cardiol. 2026;56:102587.
    PubMed         Abstract available
    
    
20. MARTIN EB, Kassira A, Stuckey A, Whittle B, et al
    A tale of two tracers - amyloid imaging with investigational radiotracers iodine ((124)I) evuzamitide and (99m)Tc-p5+14 (AT-05).
    J Nucl Cardiol. 2026;56:102451.
    PubMed         Abstract available
    
    

    
    J Nucl Med

21. ALBANO D, Lanfranchi F, Bauckneht M, Massollo M, et al
    Diagnostic Yield of [(18)F]FDG PET/CT in FUO: An Italian Multicenter Study of 929 Patients.
    J Nucl Med. 2026 Mar 5:jnumed.125.271525. doi: 10.2967/jnumed.125.271525.
    PubMed         Abstract available
    
    
22. SADIK M, Larsson M, Enqvist O, Edenbrandt L, et al
    Validation of an AI Method for Automated Lymphoma Metabolic Tumor Volume Segmentation Using a Public Benchmark PET/CT Dataset.
    J Nucl Med. 2026 Mar 5:jnumed.125.271605. doi: 10.2967/jnumed.125.271605.
    PubMed         Abstract available
    
    
23. GLANTSCHNIG L, Enke JS, Schuller BW, Fenn EJ, et al
    Initial Clinical Experience with [(177)Lu]Lu-RTX-2358 Radiopharmaceutical Therapy Targeting Fibroblast Activation Protein: Biodistribution, Pharmacokinetics, and Dosimetry.
    J Nucl Med. 2026 Mar 5:jnumed.125.271031. doi: 10.2967/jnumed.125.271031.
    PubMed         Abstract available
    
    

    
    Nucl Med Commun

24. ADNAN A, Basu S
    Integrating Gallium-68 prostate-specific membrane antigen 11 and Fluorodeoxyglucose PET through Pro-PET score: rationale for routine clinical and research use in metastatic prostate cancer.
    Nucl Med Commun. 2026;47:375-379.
    PubMed        
    
    
25. AMRO S, Vinjamuri S, Dizdarevic S
    PET computed tomography policy variations across the UK: a call for harmonisation and equity of access.
    Nucl Med Commun. 2026;47:371-374.
    PubMed        
    
    
26. LEIKE T, Lima T, Saltybaeva N, Grunig H, et al
    Impact of PET/computed tomography image reconstruction methods on Hopkins score in therapy response assessment of head and neck cancer patients.
    Nucl Med Commun. 2026 Mar 4. doi: 10.1097/MNM.0000000000002135.
    PubMed         Abstract available
    
    
27. ZHAO Y, Diao W, Li Y, Zhao M, et al
    Prognostic significance of metabolic parameters from l-methyl-11C-methionine PET/computed tomography before postoperative adjuvant therapy in patients with glioma.
    Nucl Med Commun. 2026 Mar 2. doi: 10.1097/MNM.0000000000002128.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

28. CHIA PHJ, Toyonaga T, Tong J, Le H, et al
    SV2A PET reveals synaptic density loss in experimental autoimmune encephalomyelitis and in a pilot multiple sclerosis study.
    Proc Natl Acad Sci U S A. 2026;123:e2517709123.
    PubMed         Abstract available
    
    

    
    Semin Nucl Med

29. MENA E, Lindenberg L, Heng S, Choyke PL, et al
    Advances and challenges of PET imaging in bladder cancer-An update and future trends.
    Semin Nucl Med. 2026 Mar 2:S0001-2998(26)00046.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Nuclear Medicine is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum